Advancing Strategies for Proteolysis-Targeting Chimera Design
Journal of Medicinal Chemistry · 23.02.2023 · 66 (4) · 2308-2329
DOI: 10.1021/acs.jmedchem.2c01555 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 14.02.2023. Verfasst von Minglei Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117 Shandong, P. …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 148 Literaturangaben. Gefördert von: Shandong First Medical University, Postdoctoral Innovation Project of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Proteolysis-targeting chimeras (PROTACs) have shown great therapeutic potential by degrading various disease-causing proteins, particularly those related to tumors. Therefore, the introduction of PROTACs has ushered in a new chapter of antitumor drug development, marked by significant advances over recent years. Herein, we describe recent developments in PROTAC technology, focusing on design strategy, development workflow, and future outlooks. We also discuss potential opportunities and challenges for PROTAC research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117 Shandong, P. R. China.
ORCID-Profile: Minglei Li
Förderung
- Shandong First Medical University
- Postdoctoral Innovation Project of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Li, M., Zhi, Y., Liu, B., & Yao, Q. (2023). Advancing Strategies for Proteolysis-Targeting Chimera Design. Journal of Medicinal Chemistry, 66(4), 2308-2329. https://doi.org/10.1021/acs.jmedchem.2c01555
Vancouver
Li M, Zhi Y, Liu B, Yao Q. Advancing Strategies for Proteolysis-Targeting Chimera Design. Journal of Medicinal Chemistry. 2023;66(4):2308-2329. doi:10.1021/acs.jmedchem.2c01555
BibTeX
@article{Li2023,
author = {Li, Minglei and Zhi, Ying and Liu, Bo and Yao, Qingqiang},
title = {Advancing Strategies for Proteolysis-Targeting Chimera Design},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {4},
pages = {2308--2329},
doi = {10.1021/acs.jmedchem.2c01555}
}
EUVIMED